Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:

Slides:



Advertisements
Similar presentations
August 30, 2009 at CET. Ticagrelor compared with clopidogrel in patients with acute coronary syndromes – the PLATO trial.
Advertisements

Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
ESC Congress 2007 RIGTH BUNDLE BRANCH BLOCK AS RISK MARKER OF IN HOSPITAL MORTALITY IN ST- ELEVATION ACUTE MYOCARDIAL INFARCTION. A RENASICA - II SUBSTUDY.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Date of download: 5/28/2016 From: Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Elective Intra-aortic Balloon Counterpulsation During.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Varespladib and Cardiovascular Events in Patients.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effectiveness of Foot Orthoses to Treat Plantar Fasciitis:
Date of download: 6/3/2016 From: Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial.
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Prognosis of Acute Kidney Injury After.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nuisance Bleeding With Prolonged Dual Antiplatelet.
Date of download: 6/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Blood Urea Nitrogen in the Early Assessment of Acute.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Outcomes of Older Diabetic Patients After.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiarrhythmic Drugs for Maintaining Sinus Rhythm.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Non–ST-Segment Elevation Acute Coronary.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: N-terminal pro brain natriuretic peptide on admission.
Copyright © 2014 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Arch Intern Med. 2004;164(13): doi: /archinte Figure Legend:
From: A Randomized Trial Comparing Acupuncture, Simulated Acupuncture, and Usual Care for Chronic Low Back Pain Arch Intern Med. 2009;169(9): doi: /archinternmed
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Risk stratification in ACS F.Shakib .cardiologigst
Figure 1 Patient flow chart.
Figure 2 Kaplan–Meier estimates of event-free survival (survival to the combined endpoint). From: Long-term outcomes of patients with acute myocardial.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
Giuseppe Biondi Zoccai
Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,
Baseline characteristics of patients
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
European Heart Association Journal 2007 April
European Society of Cardiology 2003
Recent Temporal Trends in the Presentation, Management, and Outcome of Women Hospitalized with Acute Coronary Syndromes  Avi Sabbag, MD, Shlomi Matetzky,
Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study.
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
Date: Presenter: Ryan Chen
RIDDLE-NSTEMI Trial design: Patients with NSTEMI were randomized to either immediate (within 2 hours) intervention or delayed (within 72 hours) intervention.
Figure 4 Observational studies on multiple treatment strategies
Global Registry of Acute Coronary Events: GRACE
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.
Baseline Q Waves and Time From Symptom Onset to ST-segment Elevation Myocardial Infarction: Insights From PLATO on the Influence of Sex  Naji Kholaif,
MRRs and EMRRs for women with ACS
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Presentation transcript:

From: External Validity of Clinical Trials in Acute Myocardial Infarction Arch Intern Med. 2007;167(1):68-73. doi:10.1001/archinte.167.1.68 Figure Legend: Patient inclusion flowchart. ACS indicates acute coronary syndrome; GRACE, Global Registry of Acute Coronary Events; LBBB, left bundle-branch block; NSTEMI, non–ST-segment elevation myocardial infarction; STE, ST-segment elevation; RCT, randomized clinical trial. Date of download: 10/11/2017

From: External Validity of Clinical Trials in Acute Myocardial Infarction Arch Intern Med. 2007;167(1):68-73. doi:10.1001/archinte.167.1.68 Figure Legend: Selected hospital outcomes and postdischarge to 6-month mortality. Unadjusted P<.001 across the 3 groups for all outcomes. RCT indicates randomized clinical trial. Reported P values adjusted for variables in the GRACE (Global Registry of Acute Coronary Events) risk model plus reperfusion and delay from symptom onset to arrival at the hospital. Date of download: 10/11/2017

From: External Validity of Clinical Trials in Acute Myocardial Infarction Arch Intern Med. 2007;167(1):68-73. doi:10.1001/archinte.167.1.68 Figure Legend: Crude and adjusted odds ratios (95% confidence intervals) for hospital death comparing eligible patients vs randomized clinical trial (RCT) participants. *Adjusted for GRACE (Global Registry of Acute Coronary Events) risk score, use and type of reperfusion (primary percutaneous coronary intervention only, fibrinolytic only, both, or neither), and delay from symptom onset to hospital admission (<2, 2-5.9, and ≥6 hours); P = .38 for reperfusion by trial type interaction in eligible patients vs RCT participants. †Adjusted for the GRACE risk score. Date of download: 10/11/2017